can semaglutide cause suicidal thoughts A recent post hoc analysis published in Obesity found tirzepatide vs. placebo was not associated with increased risk of depression symptoms. Rates of ideation and behavior were low and similar to Suicidal ideation more commonly reported

Rising awareness of the cardiovascular and renal benefits associated with GLP-1 receptor agonists has also contributed to their expanding utilization

Most analysts expect a filing in late 2027 at the earliest, with potential approval in 2028

Melatonin improves mitochondrial function by preventing mitochondrial fission in cadmium-induced rat proximal tubular cell injury via SIRT1-PGC-1 pathway activation

Gastroenterology 139(2):456463

Appetite Regulation: The interaction with POMC/CART neurons in the hypothalamus

In summary, tirzepatide is the first dual receptor agonist that was recently approved for the treatment of T2D by the FDA